Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs17714284 | chr7:127147205 | G/A | 6.81E-7 | 129 | 42.18 | 37.53 | 100.87 | KM Plot |
| TGCT | rs17733988 | chr7:127657793 | G/A | 6.2E-5 | 133 | 46.07 | 37.32 | 9.77 | KM Plot |
| TGCT | rs17735366 | chr7:127760886 | A/G | 1.24E-13 | 134 | 45.47 | 35.37 | 17.1 | KM Plot |
| TGCT | rs17737966 | chr8:361499 | A/G | 0.000147 | 134 | 47.77 | 40.57 | 42.1 | KM Plot |
| TGCT | rs17748862 | chr10:27572440 | C/T | 2.18E-9 | 134 | 24.35 | 46.07 | 42.18 | KM Plot |
| TGCT | rs17784025 | chr2:29532167 | A/G | 6.16E-8 | 131 | 45.1 | 23.37 | 13.18 | KM Plot |
| TGCT | rs17784115 | chr2:29533642 | C/T | 6.53E-8 | 132 | 45.1 | 24.23 | 13.18 | KM Plot |
| TGCT | rs1784786 | chr11:111486043 | A/G | 4.79E-7 | 134 | 45.1 | 41.33 | 20.6 | KM Plot |
| TGCT | rs1799598 | chr3:172409798 | A/G | 0.000108 | 130 | 45.1 | 37.7 | 25.57 | KM Plot |
| TGCT | rs183560 | chr17:39363166 | A/G | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs183561 | chr17:39350697 | T/A | 7.11E-7 | 133 | 13.17 | 46.03 | 42.1 | KM Plot |
| TGCT | rs1845230 | chr18:1203097 | T/C | 8.67E-5 | 130 | 95.23 | 28.67 | 45.83 | KM Plot |
| TGCT | rs1860551 | chr17:39388852 | T/C | 7.83E-7 | 132 | 13.17 | 56.7 | 42.27 | KM Plot |
| TGCT | rs187358436 | chr6:156991347 | T/C | 0.000115 | 133 | 41.27 | 60.63 | 59.27 | KM Plot |
| TGCT | rs1882542 | chr12:107070049 | A/C | 0.000103 | 134 | 44.52 | 45.1 | 28.8 | KM Plot |